Insider Selling: Questcor Pharmaceuticals Director Sells 20,000 Shares of Stock (QCOR)
Questcor Pharmaceuticals (NASDAQ:QCOR) Director Broadwood Partners Lp sold 20,000 shares of the stock on the open market in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $65.00, for a total value of $1,300,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Questcor Pharmaceuticals (NASDAQ:QCOR) traded down 1.11% on Monday, hitting $63.02. 1,854,264 shares of the company’s stock traded hands. Questcor Pharmaceuticals has a 52-week low of $24.75 and a 52-week high of $74.76. The stock has a 50-day moving average of $55.36 and a 200-day moving average of $59.70. The company has a market cap of $3.711 billion and a P/E ratio of 14.64.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Questcor Pharmaceuticals in a research note to investors on Friday. They now have a $68.00 price target on the stock. Separately, analysts at Mizuho reiterated a “buy” rating on shares of Questcor Pharmaceuticals in a research note to investors on Tuesday, November 26th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $77.00.
Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.